Normunity, which combines the words normal and immunity, is a West Haven and Boston-based biotech that addresses T cell exclusion — that is, when T cells can’t get into tumors.
Normunity wants to break down the wall that’s standing between the immune system and cancer cells using antibodies. Once that happens, either the body’s normal immune system (hence the name) or a different immunotherapy can enter the tumors and do their job.